| Issue |
BIO Web Conf.
Volume 111, 2024
2024 6th International Conference on Biotechnology and Biomedicine (ICBB 2024)
|
|
|---|---|---|
| Article Number | 01013 | |
| Number of page(s) | 6 | |
| Section | Genetic Engineering and Biotechnology Innovation | |
| DOI | https://doi.org/10.1051/bioconf/202411101013 | |
| Published online | 31 May 2024 | |
Exploring the Therapeutic Potential of Paenibacillus-Derived Exopolysaccharides in Colorectal Cancer: A Cellular and Inflammatory Perspective
The University of Manchester, Manchester, United Kingdom
* Corresponding author: luoxch98@163.com
This study seeks to explore the possibility of discovering a novel therapeutic agent for colorectal cancer. The exopolysaccharide (EPS-J12) from Paenibacillus spp. PYQ-J12 was used as the experimental subject. Caco-2 cells were used to simulate impaired intestinal epithelial cells, and TNF-α was used to cause inflammation of the cells, which was expected to investigate the reparative functions of EPS on inflamed, damaged Caco-2 cells and its influence on the expression levels of different inflammatory factors. Cell viability was used as an indicator to evaluate the reparative effects of the polysaccharide. The expression levels of different cytokines, including Interleukin 6 (IL-6), IL-8, IL-10, IL-1β, and Interleukin 12A (IL-12A), were tested. The findings indicated that EPS has a certain repair effect on inflammatory damage and can cause a reduction in the expression levels of inflammatory factors, thereby controlling inflammation. Therefore, it has the potential to become a new therapeutic option.
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.